Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2020 1
2021 2
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation.
Pagani L, Chinello C, Risca G, Capitoli G, Criscuolo L, Lombardi A, Ungaro R, Mangioni D, Piga I, Muscatello A, Blasi F, Favalli A, Martinovic M, Gori A, Bandera A, Grifantini R, Magni F. Pagani L, et al. Among authors: favalli a. Int J Mol Sci. 2023 Feb 10;24(4):3570. doi: 10.3390/ijms24043570. Int J Mol Sci. 2023. PMID: 36834989 Free PMC article.
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response.
Pesce E, Manfrini N, Cordiglieri C, Santi S, Bandera A, Gobbini A, Gruarin P, Favalli A, Bombaci M, Cuomo A, Collino F, Cricrì G, Ungaro R, Lombardi A, Mangioni D, Muscatello A, Aliberti S, Blasi F, Gori A, Abrignani S, De Francesco R, Biffo S, Grifantini R. Pesce E, et al. Among authors: favalli a. Front Immunol. 2022 Jan 17;12:785941. doi: 10.3389/fimmu.2021.785941. eCollection 2021. Front Immunol. 2022. PMID: 35111156 Free PMC article.
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
Notarbartolo S, Ranzani V, Bandera A, Gruarin P, Bevilacqua V, Putignano AR, Gobbini A, Galeota E, Manara C, Bombaci M, Pesce E, Zagato E, Favalli A, Sarnicola ML, Curti S, Crosti M, Martinovic M, Fabbris T, Marini F, Donnici L, Lorenzo M, Mancino M, Ungaro R, Lombardi A, Mangioni D, Muscatello A, Aliberti S, Blasi F, De Feo T, Prati D, Manganaro L, Granucci F, Lanzavecchia A, De Francesco R, Gori A, Grifantini R, Abrignani S. Notarbartolo S, et al. Among authors: favalli a. Sci Immunol. 2021 Aug 10;6(62):eabg5021. doi: 10.1126/sciimmunol.abg5021. Sci Immunol. 2021. PMID: 34376481 Free article.
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study.
Favalli EG, Gobbini A, Bombaci M, Maioli G, Biggioggero M, Pesce E, Favalli A, Martinovic M, Fabbris T, Marchisio E, Bandera A, Gori A, Abrignani S, Grifantini R, Caporali R. Favalli EG, et al. Among authors: favalli a. Front Med (Lausanne). 2022 Mar 11;9:850858. doi: 10.3389/fmed.2022.850858. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35360719 Free PMC article.
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations.
Favalli A, Favalli EG, Gobbini A, Zagato E, Bombaci M, Maioli G, Pesce E, Donnici L, Gruarin P, Biggioggero M, Curti S, Manganaro L, Marchisio E, Bevilacqua V, Martinovic M, Fabbris T, Sarnicola ML, Crosti M, Marongiu L, Granucci F, Notarbartolo S, Bandera A, Gori A, De Francesco R, Abrignani S, Caporali R, Grifantini R. Favalli A, et al. Front Immunol. 2022 Jun 10;13:873195. doi: 10.3389/fimmu.2022.873195. eCollection 2022. Front Immunol. 2022. PMID: 35757699 Free PMC article.
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study.
Favalli EG, Gobbini A, Bombaci M, Maioli G, Biggioggero M, Pesce E, Favalli A, Martinovic M, Fabbris T, Marchisio E, Bandera A, Gori A, Abrignani S, Grifantini R, Caporali R. Favalli EG, et al. Among authors: favalli a. Front Med (Lausanne). 2022 May 4;9:923790. doi: 10.3389/fmed.2022.923790. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35602493 Free PMC article.
Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals.
Galeota E, Bevilacqua V, Gobbini A, Gruarin P, Bombaci M, Pesce E, Favalli A, Lombardi A, Vincenti F, Ongaro J, Fabbris T, Curti S, Martinovic M, Toccafondi M, Lorenzo M, Critelli A, Clemente F, Crosti M, Sarnicola ML, Martinelli M, La Sala L, Espadas A, Donnici L, Borghi MO, De Feo T, De Francesco R, Prati D, Meroni PL, Notarbartolo S, Geginat J, Gori A, Bandera A, Abrignani S, Grifantini R. Galeota E, et al. Among authors: favalli a. Clin Immunol. 2024 Apr;261:110164. doi: 10.1016/j.clim.2024.110164. Epub 2024 Feb 28. Clin Immunol. 2024. PMID: 38417765
Laser-plasmas in the relativistic-transparency regime: Science and applications.
Fernández JC, Cort Gautier D, Huang C, Palaniyappan S, Albright BJ, Bang W, Dyer G, Favalli A, Hunter JF, Mendez J, Roth M, Swinhoe M, Bradley PA, Deppert O, Espy M, Falk K, Guler N, Hamilton C, Hegelich BM, Henzlova D, Ianakiev KD, Iliev M, Johnson RP, Kleinschmidt A, Losko AS, McCary E, Mocko M, Nelson RO, Roycroft R, Santiago Cordoba MA, Schanz VA, Schaumann G, Schmidt DW, Sefkow A, Shimada T, Taddeucci TN, Tebartz A, Vogel SC, Vold E, Wurden GA, Yin L. Fernández JC, et al. Among authors: favalli a. Phys Plasmas. 2017 May;24(5):056702. doi: 10.1063/1.4983991. Epub 2017 May 30. Phys Plasmas. 2017. PMID: 28652684 Free PMC article.